Search

everythinglearnresearchcommunity

for

Search:↓

No cure for female pattern hair loss, but various effective treatments exist.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Overweight women with PCOS are more likely to have excess male hormones.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

AGA can occur in children with family history; early diagnosis and treatment important.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Sphinganine can reduce hair loss and improve scalp health.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Gut health affects skin diseases, and probiotics might help.

SHBG may be a useful early indicator and treatment target for PCOS.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.